צפוויט פורטה תרחיף
vitamed pharmaceutical industries ltd - cefalexin as monohydrate - אבקה להכנת תרחיף - cefalexin as monohydrate 250 mg / 5 ml - cefalexin - cefalexin - antibiotic for the treatment of infections caused by micro-organisms sensitive to cephalexin.
צפוויט 250
vitamed pharmaceutical industries ltd - cefalexin as monohydrate - קפסולות - cefalexin as monohydrate 250 mg - cefalexin - cefalexin - antibiotic for the treatment of infections caused by micro-organisms sensitive to cephalexin.
צפוויט פורטה 500
vitamed pharmaceutical industries ltd - cefalexin as monohydrate - קפסולות - cefalexin as monohydrate 500 mg - cefalexin - cefalexin - treatment of infections caused by cephalexin susceptible microorganisms.
פלוקונזול 150 תרו
taro international ltd - fluconazole 150 mg - capsules - fluconazole - cryptococcosis. systemic candidiasis. mucosal candidiasis. vaginal candidiasis. dermatomycosis including tinea pedis, tinea corporis, tinea cruris, tinea versicolor and candida infections where topical therapy is considered inapproppriate due to the site, severity or extent of the infection.
פלוקונאזול טבע 150 מג
abic marketing ltd, israel - fluconazole - קפסולות - fluconazole 150 mg - fluconazole - fluconazole - cryptococcosis. - systemic candidiasis. - mucosal candidiasis. - vaginal candidiasis. - dermatomycosis.
ויפנד 50 מג טבליות מצופות
pfizer pfe pharmaceuticals israel ltd - voriconazole - טבליות מצופות פילם - voriconazole 50 mg - voriconazole - voriconazole - treatment of: invasive aspergillosis, fluconazole-resistant serious invasive candida infections (including c. krusei) serious fungal infections caused by scedosporium spp. and fusarium spp. vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.
ויפנד 50 מג טבליות מצופות
pfizer pfe pharmaceuticals israel ltd - voriconazole - טבליות מצופות פילם - voriconazole 50 mg - voriconazole - voriconazole - treatment of: invasive aspergillosis, fluconazole-resistant serious invasive candida infections (including c. krusei) serious fungal infections caused by scedosporium spp. and fusarium spp. vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.
ויפנד 200 מג אבקה להזרקה
pfizer pfe pharmaceuticals israel ltd - voriconazole - אבקה להכנת תמיסה לאינפוזיה - voriconazole 200 mg/vial - voriconazole - voriconazole - treatment of :- invasive aspergillosis fluconazole-resistant serious invasive candida infections (including c. krusei) , - serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.
ויפנד 200 מ"ג אבקה להזרקה
pfizer pharmaceuticals israel ltd - voriconazole 200 mg/vial - powder for solution for infusion - voriconazole - treatment of : - invasive aspergillosis fluconazole-resistant serious invasive candida infections (including c. krusei), - serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.
ויפנד 200 מג אבקה להכנת תמיסה לעירוי
pfizer pfe pharmaceuticals israel ltd - voriconazole - אבקה להכנת תמיסה לאינפוזיה - voriconazole 200 mg/vial - voriconazole - voriconazole - treatment of :- invasive aspergillosis fluconazole-resistant serious invasive candida infections (including c. krusei) , - serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.